Priyanka Vallabhaneni

Internal Medicine

800 NE 10th St
Oklahoma City, OK 73104

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 4 publications

Neoadjuvant ipilimumab (3 mg/kg or 10 mg/kg) and high dose IFN-α2b in locally/regionally advanced melanoma: safety, efficacy and impact on T-cell repertoire.

Neoadjuvant ipilimumab (3 mg/kg or 10 mg/kg) and high dose IFN-α2b in locally/regionally advanced melanoma: safety, efficacy and impact on T-cell repertoire.

Journal: Journal for immunotherapy of cancer

Published: July 31, 2018

A unique gene expression signature is significantly differentially expressed in tumor-positive or tumor-negative sentinel lymph nodes in patients with melanoma.

A unique gene expression signature is significantly differentially expressed in tumor-positive or tumor-negative sentinel lymph nodes in patients with melanoma.

Journal: Melanoma research

Published: August 22, 2017

Expression profiles of immune-related genes are associated with neoadjuvant ipilimumab clinical benefit.

Expression profiles of immune-related genes are associated with neoadjuvant ipilimumab clinical benefit.

Journal: Oncoimmunology

Published: July 20, 2016

Metronidazole induced liver injury: a rare immune mediated drug reaction.

Metronidazole induced liver injury: a rare immune mediated drug reaction.

Journal: Case reports in gastrointestinal medicine

Published: November 05, 2013

Showing 1-4 of 4

Last Updated: 09/26/2026